Rezolute, Inc. Files Definitive Proxy Statement for Dec 5 Meeting
Ticker: RZLT · Form: DEF 14A · Filed: Oct 21, 2024 · CIK: 1509261
| Field | Detail |
|---|---|
| Company | Rezolute, Inc. (RZLT) |
| Form Type | DEF 14A |
| Filed Date | Oct 21, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
Related Tickers: RZLT
TL;DR
Rezolute (RZLT) proxy filed for Dec 5 meeting. Shareholders vote soon.
AI Summary
Rezolute, Inc. filed its definitive proxy statement on October 21, 2024, for its annual meeting of stockholders scheduled for December 5, 2024. The company, formerly known as AntriaBio, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. The filing details information required for the proxy statement under Section 14(a) of the Securities Exchange Act of 1934.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on matters presented at the annual meeting, impacting the company's governance and future direction.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) providing information to shareholders, not an event that inherently increases risk.
Key Players & Entities
- Rezolute, Inc. (company) — Registrant
- AntriaBio, Inc. (company) — Former company name
- 20241205 (date) — Annual meeting date
- 20241021 (date) — Filing date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is required by the SEC to provide shareholders with information necessary to vote on matters at a company's annual meeting.
When is Rezolute, Inc.'s annual meeting of stockholders scheduled?
Rezolute, Inc.'s annual meeting of stockholders is scheduled for December 5, 2024.
What was Rezolute, Inc.'s former company name?
Rezolute, Inc. was formerly known as AntriaBio, Inc., with a name change date of January 14, 2013.
What is Rezolute, Inc.'s Standard Industrial Classification (SIC) code?
Rezolute, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Rezolute, Inc. incorporated?
Rezolute, Inc. is incorporated in Nevada (NV).
Filing Stats: 4,902 words · 20 min read · ~16 pages · Grade level 12.6 · Accepted 2024-10-21 16:41:00
Filing Documents
- tm2425798-2_def14a.htm (DEF 14A) — 655KB
- bc_tsr-4c.jpg (GRAPHIC) — 70KB
- bc_netincome-4c.jpg (GRAPHIC) — 70KB
- px_24rezolutepg01-bw.jpg (GRAPHIC) — 187KB
- px_24rezolutepg02-bw.jpg (GRAPHIC) — 160KB
- 0001104659-24-110244.txt ( ) — 1264KB
From the Filing
DEF 14A 1 tm2425798-2_def14a.htm DEF 14A tm2425798-2_def14a - block - 5.2445752s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Rezolute, Inc. (Name of Registrant as Specified in its Charter) Not Applicable (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 TABLE OF CONTENTS REZOLUTE, INC. NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS December 5, 2024 3:00 p.m. Pacific Time To the Stockholders of Rezolute, Inc.: The 2025 Annual meeting of the stockholders (the " Annual Meeting ") of Rezolute, Inc., a Nevada corporation (the " Company "), will be held via a virtual meeting on Thursday, December 5, 2024 at 3:00 p.m. Pacific Time. You may virtually attend the Annual Meeting, vote, and submit a question during the Annual Meeting by visiting https://agm.issuerdirect.com/rzlt. The Annual Meeting will be held for the following purposes: (1) To elect Nevan Charles Elam, Gil Labrucherie, Philippe Fauchet, Nerissa Kreher, Wladimir Hogenhuis, and Young-Jin Kim to the Company's Board of Directors until the 2026 Annual Meeting. (2) To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending on June 30, 2025. (3) To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers, or NEOs, as disclosed in the Executive Compensation section of this Proxy Statement. (4) To approve an amendment to the Company's Articles of Incorporation to increase the Company's authorized common stock from 100,000,000 shares of common stock to an aggregate of 165,000,000 shares of common stock (the " Share Increase Proposal ") (5) To approve an amendment to the 2021 Stock Incentive Plan, as amended, (the " 2021 Equity Plan "), to increase the number of shares available for issuance thereunder from 10,700,000 shares of common stock to an aggregate of 14,450,000 shares of common stock (the " 2021 Equity Plan Amendment Proposal "). (6) To authorize an adjournment of the meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the Share Increase Proposal (the " Adjournment Proposal "). (7) To transact such other business as may properly come before the meeting, or any postponements or adjournments thereof. All stockholders of record at the close of business on October 7, 2024 are entitled to notice of and to vote at such meeting. The date on which we anticipate this Proxy Statement and the accompanying proxy will be first sent or given to stockholders will be on or about October 23, 2024. Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to Be Held on Thursday, December 5, 2024. Pursuant to the rules of the Securities and Exchange Commission (the " SEC "), the Company has elected to provide access to its proxy materials at www.iproxydirect.com/RZLT; and https://agm.issuerdirect.com/ rzlt which includes this Notice, the accompanying Proxy Statement and Proxy Card. All stockholders are cordially invited to virtually attend the Annual Meeting. If you virtually attend the meeting, you may withdraw your proxy and vote your shares at the meeting. Your vote is extremely important. Whether or not you expect to virtually attend the Annual Meeting, please vote by mail, Internet or telephone as described in the enclosed proxy materials. By order of the Board of Directors /s/ Nevan Charles Elam Nevan Charles Elam Chief Executive Officer and Acting Chairman of the Board Redwood City, California TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION 1 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND VOTING 1 PROPOSAL 1 ELECTION OF DIRECTORS 6 PROPOSAL 2 ACCOUNTANT PROPOSAL 17 PROPOSAL 3 SAY-ON-PAY PROPOSAL 19 PROPOSAL 4 SHARE INCREASE PROPOSAL 31 PROPOSAL 5 AMENDMENT OF 2021 INCENTIVE COMPENSATION PLAN 32 PROPOSAL 6 ADJOURNMENT PROPOSAL 36 OTHER MATTERS 37 COSTS OF PROXY SOLICITATION 37 NOTICE AND ACCESS 37 AVAILABLE INFORMATION 37 i TABLE OF CONTENTS 2025 ANNUAL MEETING OF STOCKHOLDERS to be held